Vaccines in oncology: background and clinical potential

被引：7

作者：

Armstrong, AC ^{[1
]}

Hawkins, RE

机构：

[1] Univ Manchester, CRC, Dept Med Oncol, Manchester M20 4BX, Lancs, England

[2] Christie Hosp NHS Trust, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England

来源：

BRITISH JOURNAL OF RADIOLOGY | 2001年 / 74卷 / 887期

关键词：

D O I：

10.1259/bjr.74.887.740991

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Cancer is one of the leading causes of death in Western society. Despite improvements in screening, diagnosis and treatment of cancer, many patients ultimately succumb to their disease. Advances in molecular biology and our increased understanding of how the immune system functions have led to an intense interest in the development of cancer vaccines.

引用

页码：991 / 1002

页数：12

共 83 条

[31]

HAWKINS RE, 1994, BLOOD, V83, P3279

[32] Tumor-induced immunosuppression: A barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine [J].

Hsieh, CL ;

Chen, DS ;

Hwang, LH .

HUMAN GENE THERAPY, 2000, 11 (05) :681-692

[33] Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - Long-term results of a clinical trial [J].

Hsu, FJ ;

Caspar, CB ;

Czerwinski, D ;

Kwak, LW ;

Liles, TM ;

Syrengelas, A ;

TaidiLaskowski, B ;

Levy, R .

BLOOD, 1997, 89 (09) :3129-3135

[34] Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells [J].

Hsu, FJ ;

Benike, C ;

Fagnoni, F ;

Liles, TM ;

Czerwinski, D ;

Taidi, B ;

Engleman, EG ;

Levy, R .

NATURE MEDICINE, 1996, 2 (01) :52-58

[35] High levels of a major histocompatibility complex II self peptide complex on dendritic cells from the T cell areas of lymph nodes [J].

Inaba, K ;

Pack, M ;

Inaba, M ;

Sakuta, H ;

Isdell, F ;

Steinman, RM .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (05) :665-672

[36]

Jager E, 1997, INT J CANCER, V71, P142, DOI 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO

[37]

2-0

[38] ANTIGEN PRESENTATION BY CHEMICALLY MODIFIED SPLENOCYTES INDUCES ANTIGEN-SPECIFIC T-CELL UNRESPONSIVENESS INVITRO AND INVIVO [J].

JENKINS, MK ;

SCHWARTZ, RH .

JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) :302-319

[39]

Kaplan JM, 1999, J IMMUNOL, V163, P699

[40] IDENTIFICATION OF A HUMAN-MELANOMA ANTIGEN RECOGNIZED BY TUMOR-INFILTRATING LYMPHOCYTES ASSOCIATED WITH IN-VIVO TUMOR REJECTION [J].

KAWAKAMI, Y ;

ELIYAHU, S ;

DELGADO, CH ;

ROBBINS, PF ;

SAKAGUCHI, K ;

APPELLA, E ;

YANNELLI, JR ;

ADEMA, GJ ;

MIKI, T ;

ROSENBERG, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6458-6462

← 1 2 3 4 5 6 7 8 9 →